LUMINARA
a Phase 2b, two cohort, randomised, double blind, placebo controlled, multicentre, dose-ranging study of AZD5462 in stable patients with chronic heart failure
- Stadium
- followup
- Middel
- AZD5462
- Populatie
- Hartfalen
- Fase
- IIb
- First Patient In
- 15 augustus 2024
- Last Patient In
- 11 juli 2025
- Last Patient Last Visit
- 16 februari 2026
National Lead
dr. J. Schaap
Cardioloog
Studiedirecteur